About SHAAR Hub

SHAAR is a healthcare innovation hub created and led by Shaare Zedek Medical Center and Arieli Capital.

Founding Partners:

Partnerships:

Our Ecosystem:

Our Story

Located within Shaare Zedek Medical Center in Jerusalem,  SHAAR, Shaare Zedek Arieli Innovation Hub,  combines SZMC’s medical expertise and world-class facilities with Arieli’s investment experience and proven track record in fostering innovation and growth.
SHAAR, Hebrew for “gateway”, aims to bridge innovation and capital and stands as a collaborative hub by creating an environment that nurtures pioneering healthcare startups, projects and cutting-edge medical research with strategic professional and financial support.

SHAAR is where startups, investors, medical professionals and industry leaders unite to advance and support the next generation of healthcare technologies and entrepreneurs. 

Shaare
Zedek

Shaare Zedek Medical Center, Jerusalem’s largest multidisciplinary facility, is dedicated to delivering advanced care across numerous specialties. Treating over 1,000,000 patients annually, this 1000-bed center is committed to continual improvement and excellence in patient care in its 30 departments and 70 outpatient clinics. Offering a wide range of medical services, Shaare Zedek stands at the forefront of healthcare, combining cutting-edge treatments with compassionate care, reflecting its longstanding tradition of serving the diverse population of Jerusalem and beyond.

Shaare Zedek
Scientific Ltd.

Shaare Zedek Scientific Ltd. (Mada’it), the innovation and research arm of Jerusalem’s rapidly expanding Shaare Zedek Medical Center, serves as a bridge between Healthtech industry partners and the hospital, treating over a million cases annually.  Specializing in transforming research into novel treatments, Mada’it leverages the hospital’s facilities, patient base, and expert team. Its mission is to extend Shaare Zedek’s clinical and research achievements to benefit the global healthcare community, ensuring ongoing advancement in medical science.

 

 

 

Arieli
Capital

Arieli Capital is a multifaceted investment firm that is focused on being an active investor in the next generation of technology companies. Arieli continuously strives to identify and support companies creating real impact, while keeping financial returns as the primary objective. Arieli is also a recognized global leader in innovation with deep governmental, academic, and corporate relationships and partnerships. Arieli Capital operates four core businesses: Arieli Family Office, Arieli Innovation, Arieli Advisory and Arieli Innovation Fund. The Arieli team is primarily based in Israel with offices in New York and London.

Team

Prof. Dan Turner

Chairman of the Board, Shaare Zedek Scientific (Mada’it) & Co-Founder, SHAAR
Dan Turner is Professor of Paediatrics at the Hebrew University of Jerusalem and holds a PhD degree in clinical epidemiology from the University of Toronto. Professor Turner serves as the deputy, director general of Shaare Zedek Medical Center for R&D and is the founder and the current Chair of SZC.
Linkedin

Evan Renov

Co-Founder and CEO, Arieli Capital & Co-Founder, SHAAR
View Linkedin Profile
Linkedin

Renana Ofan, Phd

CEO, Shaare Zedek Scientific (Mada’it) & Co-Director, SHAAR
View Linkedin Profile
Linkedin

Eric Bentov

Co-Founder and Managing Partner, Arieli Capital & Co-Founder, SHAAR
View Linkedin Profile
Linkedin

Nurit Kantarovich

VP Strategic Partnerships, Arieli Capital & Co-Director, SHAAR

Or Haviv

Partner and Head of Global Innovation, Arieli Capital
View Linkedin Profile
Linkedin

Anna Katz

Clinical Trials Lead at Shaare Zedek Scientific & SHAAR
View Linkedin Profile
Linkedin

Michael Lavie Salomon

VP Innovation, Arieli Capital
View Linkedin Profile
Linkedin

Nataf Dgani

Head of Marketing, Arieli Capital
View Linkedin Profile
Linkedin

Tal (Menachem) Arusi

Project coordinator, Shaare Zedek Scientific (Madait)
View Linkedin Profile
Linkedin

Join Our Newsletter

Thank You!

We've received your details successfully.